Cargando…

Pregnancy with anti-PP1Pk antibody managed with prednisolone and low-molecular-weight heparin – A case report and literature review

The anti-PP1Pk is a rare antibody associated with recurrent miscarriages, mainly in the first half of pregnancy. There seems to be a direct correlation between the antibody titer and risk of miscarriage. As this is a rare entity, few case reports have been published. The most frequently proposed the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nascimento, Sara, Rodrigues, Marta, Gonçalves Henriques, Manuel, Paixão Duarte, Fernanda, Barra, António, Matos, Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334791/ https://www.ncbi.nlm.nih.gov/pubmed/32642450 http://dx.doi.org/10.1016/j.crwh.2020.e00238

Ejemplares similares

Effect of Poly(L-lysine) and Heparin Coatings on the Surface of Polyester-Based Particles on Prednisolone Release and Biocompatibility
por: Mohamed, Abdelrahman, et al.
Publicado: (2021)

Prednisolone and azathioprine are effective in DPPX antibody–positive autoimmune encephalitis
por: Stoeck, Katharina, et al.
Publicado: (2015)

First Case in Korea of a Patient With Anti-PP1Pk Antibodies: Successful Blood Management via Acute Normovolemic Hemodilution
por: Ha, Changhee, et al.
Publicado: (2019)

Gasorelin/prednisolone: COVID-19 infection and weight increase : case report
Publicado: (2020)

Successful Pregnancy in a Case of Behçet's Disease after Treatment with Prednisolone
por: Nishii, Shogo, et al.
Publicado: (2020)

Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial
por: Gomaa, Mostafa F., et al.
Publicado: (2014)

Heparin/low molecular weight heparins: Thrombocytopenia: 7 case reports
Publicado: (2021)

Effect of prednisolone on language function in children with autistic spectrum disorder: a randomized clinical trial()()()
por: Brito, Adriana Rocha, et al.
Publicado: (2020)

Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels
por: Bengalorkar, Girish M., et al.
Publicado: (2011)

Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
por: Chen, Jianle, et al.
Publicado: (2019)

Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014)

Immune-globulin/prednisolone: No response during third trimester of pregnancy: case report
Publicado: (2021)

Comparison of the Efficacy of Combination Therapy of Prednisolone - Acyclovir with Prednisolone Alone in Bell’s Palsy
por: KHAJEH, Ali, et al.
Publicado: (2015)

Prednisolone: Relapse of coronavirus disease-2019 following misuse of prednisolone: case report
Publicado: (2020)

Dipyrone/prednisolone/prednisolone sodium succinate: Acute urticaria and hyperglycaemia: case report
Publicado: (2021)

Characterization of prickle isoform-specific pk (pk1) and pk (sple1) mutations in Drosophila melanogaster
por: Lilienthal, Anthony J, et al.
Publicado: (2022)

A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin
por: Tao, Ende, et al.
Publicado: (2020)

Role of Low Molecular Weight Heparin in the Management of Unexplained Recurrent Pregnancy Loss: A Review of Literature
por: Awolumate, Oluwatayo J, et al.
Publicado: (2020)

Women’s values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review
por: León-García, Montserrat, et al.
Publicado: (2022)

The Effect of Prednisolone Treatment on Pregnancy Rates in in vitro Fertilization Patients with Positive Thyroid Autoantibodies
por: Gokce, Sefik, et al.
Publicado: (2021)

Arterial indications for the low molecular weight heparins
por: Ageno, Walter, et al.
Publicado: (2001)

Low-Molecular-Weight Heparin and Unfractionated Heparin Decrease Th-1, 2, and 17 Expressions
por: Huang, Jing-Ning, et al.
Publicado: (2014)

Is the Incidence Trend of Heparin-Induced Thrombocytopenia Decreased by the Increased Use of Low-Molecular-Weight-Heparin?
por: Al-Eidan, Fahad A S
Publicado: (2015)

Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients
por: Volteas, Panagiotis, et al.
Publicado: (2022)

Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
por: Shute, Janis Kay
Publicado: (2023)

1384. RSV Monoclonal Antibody (MK-1654) Phase 1 Pharmacokinetics (PK) in Healthy Adults and Population PK Modeling to Support Pediatric Development
por: Maas, Brian, et al.
Publicado: (2018)

Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes
por: Balevic, Stephen J, et al.
Publicado: (2022)

In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195
por: Guedes, Carlos Eduardo Sampaio, et al.
Publicado: (2018)

Pharmacokinetic and urinary profiling reveals the prednisolone/cortisol ratio as a valid biomarker for prednisolone administration
por: Van Meulebroek, Lieven, et al.
Publicado: (2017)

Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome
por: XIAO, JING, et al.
Publicado: (2013)

Does intrauterine injection of low-molecular-weight heparin improve the clinical pregnancy rate in intracytoplasmic sperm injection?
por: Kamel, Ahmed Mohamed, et al.
Publicado: (2016)

Low molecular weight heparins use in pregnancy: a practice survey from Greece and a review of the literature
por: Papadakis, E., et al.
Publicado: (2019)

A point of view on hereditary thrombophilia and low-molecular-weight heparin incorporating the management in pregnancy and involving thyroidology
por: Dugalić, Stefan, et al.
Publicado: (2023)

Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar
por: Locke, Charles FS, et al.
Publicado: (2005)

The efficacy and safety of low-molecular-weight heparin and unfractionated heparin in the treatment of cerebral venous sinus thrombosis
por: Afshari, Daryoush, et al.
Publicado: (2015)

Temporality of heparin-induced antibodies: a retrospective study in outpatients undergoing hemodialysis on unfractionated heparin
por: Maharaj, Satish, et al.
Publicado: (2018)

The Appropriateness of Testing Platelet Factor 4/Heparin Antibody in Patients Suspected of Heparin-induced Thrombocytopenia
por: Jindal, Vishal, et al.
Publicado: (2018)

Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia
por: Giles, Jason B., et al.
Publicado: (2022)

Multi-PK antibodies: Powerful analytical tools to explore the protein kinase world
por: Sugiyama, Yasunori, et al.
Publicado: (2017)

Comparing Model Performance in Characterizing the PK/PD of the Anti‐Myostatin Antibody Domagrozumab
por: Tiwari, Abhinav, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ithgic6haj3emr9i7n9nsr1bli